How to Help Your Patients Save Money on Imvexxy: A Provider's Guide to Savings Programs

Cost is one of the most significant barriers to Imvexxy adherence. The starter pack retails at $543–$647 and the maintenance pack at $263–$311 without insurance — costs that are unsustainable for many patients, particularly those on Medicare who often lack Part D coverage for this medication. This guide gives prescribers a practical resource to help patients access savings and maintain treatment continuity.

Understanding the Cost Landscape for Imvexxy in 2026

Prescribers should understand the realistic cost patients face across insurance situations:

• Commercially insured (PA approved): Copay typically $30–$75/month depending on tier; eligible for Mayne Pharma Savings Card to reduce to as low as $35/prescription
• Commercially insured (prior auth required, not yet obtained): Full cash price ($263–$647) until PA is approved; savings card cannot usually bridge a PA denial
• Medicare Part D: Most plans do not cover Imvexxy; manufacturer savings cards cannot be used with Medicare; patient pays full cash price or uses GoodRx/SingleCare
• Uninsured: GoodRx can reduce maintenance pack to ~$50; SingleCare can reduce starter pack to ~$404; generic alternatives (when available) will be significantly cheaper

The Imvexxy Savings Card: What Providers Need to Know

Mayne Pharma offers the Imvexxy Savings Card at imvexxy.com/savings-information. Key details for prescribers to know and communicate to patients:

• Reduces out-of-pocket cost to as little as $35 per prescription for eligible patients
• Eligibility: Must have commercial (private) health insurance; not valid with Medicare, Medicaid, or government-funded insurance programs
• The card works in conjunction with the insurance copay, not as a substitute for insurance
• Patients must download/print the card from the Imvexxy website and present it at the pharmacy with their prescription
• Maximum savings limits may apply; the patient is responsible for amounts above the program limit

Streamlining Prior Authorization to Reduce Patient Cost Exposure

The most impactful cost intervention prescribers can make is obtaining prior authorization efficiently. Each month without a PA approval costs the patient hundreds of dollars at cash prices. Consider these PA documentation strategies:

• Submit the PA request at the same visit you write the initial prescription — don't wait for the patient to hit a rejection at the pharmacy
• Document the diagnosis explicitly: "Moderate to severe dyspareunia secondary to vulvar and vaginal atrophy due to menopause (ICD-10: N95.2)"
• For step therapy: document any prior vaginal estrogen trials, including the specific product, duration of use, and reason for discontinuation or inadequate response
• For patients who need 4 mcg specifically: note that the 4 mcg dose is not available in generic vaginal estrogen tablets (which are only 10 mcg), providing clinical justification for Imvexxy brand

Generic Alternatives as a Cost Strategy

For patients who need a more affordable option and can tolerate a formulation change, consider:

• Generic estradiol vaginal inserts (FDA-approved December 2025): Bioequivalent to Imvexxy; expected to be significantly less expensive as commercial availability increases
• Generic estradiol vaginal tablets (Vagifem generic, 10 mcg): Widely available; approximately $30–$70/month with discount coupons; appropriate for patients who don't specifically need the 4 mcg dose
• Generic estradiol vaginal cream (Estrace generic): Often the least expensive option at $15–$40/month with coupons; flexible dosing; widely available at most retail pharmacies

What to Tell Patients About GoodRx and SingleCare

When savings cards and insurance don't provide adequate coverage, discount programs like GoodRx and SingleCare can help. Key points to communicate:

• GoodRx offers Imvexxy maintenance packs for as low as $50 at participating pharmacies (81% off retail)
• GoodRx and SingleCare cannot be combined with insurance, Medicaid, or Medicare benefits
• Patients should compare GoodRx and SingleCare prices at the specific pharmacy they plan to use — prices vary by location
• Note: GoodRx and SingleCare purchases may NOT count toward insurance deductibles — patients who are working toward meeting their deductible may want to use insurance even at a higher cost if they have many upcoming claims

Suggested Workflow for New Imvexxy Prescriptions

1. Submit PA request at time of prescribing (don't wait for pharmacy rejection)
2. Check if patient has commercial insurance → direct to Mayne Pharma Savings Card (imvexxy.com/savings-information)
3. If Medicare or uninsured → compare GoodRx/SingleCare prices; or discuss switching to a more affordable generic alternative
4. For patients who can't find it in stock → direct them to medfinder.com to locate a pharmacy with Imvexxy in inventory
5. For long-term maintenance patients → recommend 90-day supply via mail order if insurance allows, to reduce pharmacy burden and per-pack cost

For additional provider resources and to learn how medfinder can support your practice's prescribing workflows, visit medfinder.com/providers.